scholarly journals Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity

2015 ◽  
Vol 5 (6) ◽  
pp. 1067-1080 ◽  
Author(s):  
Seung-Ju Cho ◽  
So-Yeon Kim ◽  
Ho-Chang Jeong ◽  
Hyeonsik Cheong ◽  
Doseok Kim ◽  
...  
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Pluripotent Stem Cell ◽  
Ischemic Injury

Novel strategies for generation and hypothermic storage of human pluripotent stem cell-derived cardiomyocytes for cell therapy applications

Cytotherapy ◽  
2017 ◽  
Vol 19 (5) ◽  
pp. e18
Author(s):  
Cláudia Correia ◽  
Alexey Koshkin ◽  
Patricia Duarte ◽  
Madalena Carido ◽  
Pedro Lima ◽  
...  
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Pluripotent Stem Cell ◽  
Human Pluripotent Stem Cell ◽  
Hypothermic Storage

Mesenchymal Stem Cell Therapy for Ex Vivo Repair of Ischemic Injury in Pig Donor Lungs

2017 ◽  
Vol 36 (4) ◽  
pp. S68 ◽  
Author(s):  
D. Nakajima ◽  
Y. Watanabe ◽  
A. Ohsumi ◽  
M. Pipkin ◽  
M. Chen ◽  
...  
Keyword(s):  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Ex Vivo ◽  
Ischemic Injury ◽  
Mesenchymal Stem Cell Therapy

scholarly journals Photodynamic Approach for Teratoma-Free Pluripotent Stem Cell Therapy Using CDy1 and Visible Light

2016 ◽  
Vol 2 (9) ◽  
pp. 604-607 ◽  
Author(s):  
Seung-Ju Cho ◽  
So-Yeon Kim ◽  
Soon-Jung Park ◽  
Naree Song ◽  
Haw-Young Kwon ◽  
...  
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Visible Light ◽  
Stem Cell Therapy ◽  
Pluripotent Stem Cell

scholarly journals Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products

2020 ◽  
Vol 7 (2) ◽  
pp. 31
Author(s):  
Brian Lee ◽  
Breanna S. Borys ◽  
Michael S. Kallos ◽  
Carlos A. V. Rodrigues ◽  
Teresa P. Silva ◽  
...  
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Pluripotent Stem Cells ◽  
Pluripotent Stem Cell ◽  
Large Scale ◽  
Process Development ◽  
High Quality ◽  
Commercial Scale ◽  
Allogeneic Cell Therapy

Allogeneic cell therapy products, such as therapeutic cells derived from pluripotent stem cells (PSCs), have amazing potential to treat a wide variety of diseases and vast numbers of patients globally. However, there are various challenges related to the manufacturing of PSCs in large enough quantities to meet commercial needs. This manuscript addresses the challenges for the process development of PSCs production in a bioreactor, and also presents a scalable bioreactor technology that can be a possible solution to remove the bottleneck for the large-scale manufacturing of high-quality therapeutic cells derived from PSCs.

scholarly journals Pluripotent stem cell therapy for retinal diseases

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Ishrat Ahmed ◽  
Robert J. Johnston Jr ◽  
Mandeep S. Singh
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Pluripotent Stem Cell ◽  
Retinal Diseases
Sign in / Sign up

Export Citation Format

Share Document